Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Trial of CMV RNA-Pulsed Dendritic Cells With Tetanus-Diphtheria Toxoid Vaccine in Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma

NCT03615404 is registered in ClinicalTrials.gov with Gary Archer Ph.D. as lead sponsor.

NCT NCT03615404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03615404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Trial of CMV RNA-Pulsed Dendritic Cells With Tetanus-Diphtheria Toxoid Vaccine in Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma
Lead sponsor
Gary Archer Ph.D.
Phase
Phase 1
Overall status
Completed
Start date
October 5, 2018
Completion date
July 2, 2020
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, malignant glioma, medulloblastoma recurrent, pediatric brain tumor, pediatric brain tumor, recurrent, pediatric glioblastoma multiforme